-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FhsSNhQNug01Tlagt/fPeXT7R5l19Ni6v7Y/91xK89OFvovGsc34m6WBVk/hlTfe YYoTwBsQz2oRYEFfAM4cQA== 0001209191-08-012263.txt : 20080221 0001209191-08-012263.hdr.sgml : 20080221 20080221201821 ACCESSION NUMBER: 0001209191-08-012263 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080219 FILED AS OF DATE: 20080221 DATE AS OF CHANGE: 20080221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Fred E CENTRAL INDEX KEY: 0001339358 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 08634466 BUSINESS ADDRESS: BUSINESS PHONE: 1 415 743 1661 MAIL ADDRESS: STREET 1: 345 CALIFORNIA STREET SUITE 2600 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-19 0 0001131324 GENOMIC HEALTH INC GHDX 0001339358 Cohen Fred E TPG VENTURES 345 CALIFORNIA STREET SUITE 3300 SAN FRANCISCO CA 94104 1 0 0 0 Common Stock 2008-02-19 4 M 0 5201 0.5768 A 48552 D Stock Option (right to buy) 0.5768 2008-02-19 4 M 0 5201 0.00 D 2011-01-12 Common Stock 5201 0 D The number of shares originally covered by the exercised option was 5,000 with an exercise price per share of $0.60. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 201 to 5,201, reducing the effective exercise price per share to $0.5768. Option became exercisable as to 1,301 shares on October 20, 2001 and as to 3,900 shares on October 20, 2004. G. Bradley Cole, Attorney-in-Fact 2008-02-21 -----END PRIVACY-ENHANCED MESSAGE-----